As COO, Baer will take primary responsibility for enterprise operational efficiency and implementing processes to accelerate growth in collaboration with leaders and partners across the firm. She will report directly to CEO, David Pyle. “We are thrilled that Candace has agreed to join the ranks of our executive roster,” said Pyle. “She is an accomplished leader with a demonstrated ability to develop high-performing teams while driving strong organic growth and delivering value to all stakeholders. Candace is highly focused on improving patient outcomes and experience.” Baer has had a productive career in healthcare and brings over two decades of leadership…
Author: Abhay Panchal
According to a report, gastroenterology has high utilization of evaluation and management codes, which increased for 2021. Medicare ASC payments for colonoscopies with lesion removals and colonoscopies and biopsies are expected to increase in 2023, according to VMG Health’s “ASCs in 2022: A Year in Review” report. These factors put gastroenterology in a great spot for growth.
ChatGPT, a product of OpenAI, has shown potential as a clinical decision-support tool in assessing patients with acute ulcerative colitis (UC) in emergency departments (ED), according to a study led by Asaf Levartovsky, MD, from the Department of Gastroenterology, Sheba Medical Center, Tel Aviv University. The study, published in the American Journal of Gastroenterology, evaluated GPT-4’s ability to gauge disease severity and decide on hospitalizations, using 20 distinct UC presentations. The AI’s assessments were consistent with expert gastroenterologists 80% of the time. However, while ChatGPT recommended hospital admission for 16 out of 18 patients, only 12 were actually hospitalized in…
The future of public health research is being revolutionized by wearable devices such as smartwatches and fitness trackers. These tools enable researchers to conduct large-scale studies on a variety of diseases, with current investigations spanning heart diseases, neurological disorders, cancers, and more. A significant project in this domain is the Apple Women’s Health Study, a collaboration between Harvard, Apple, and the NIEHS, aiming to gather menstrual cycle data from up to 1 million users to understand its correlation with various health conditions. The rise in wearables, with nearly half of Americans using them, has led to collaborations between academic medical…
One GI®, a management service organization (MSO) specializing in gastroenterology, is pleased to introduce Christa Newton as its new Chief Executive Officer (CEO). With an impressive tenure of leading multi-specialty practice healthcare systems, Christa’s appointment reaffirms the organization’s commitment to top-tier patient care. Christa previously served One GI® as the Chief Operating Officer. As COO, Christa has become a trusted leader to our physician partners and embodies the values and culture central to our organization. Christa brings a wealth of experience in propelling organizations toward heightened performance, seamless integration, and robust revenue growth. Outlining her aspirations for One GI®, she…
The research delves into the varying sedation techniques employed during the double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) procedure, a topic of debate among medical professionals worldwide. The core objective was to gauge the performance of propofol sedation, administered by non-anesthesiologists, using a target-controlled infusion (TCI) mechanism in DB-ERCP. Spanning from May 2017 to December 2020, this retrospective analysis encompassed 156 DB-ERCP patients. These individuals were either given diazepam or propofol via a TCI system for sedation. The main focus was on contrasting the instances of inadequate sedation between the two methods. The findings revealed a higher occurrence of insufficient sedation with…
ISA Pharmaceuticals announced that the first patient has been treated in its first-in-human phase 1 trial of its novel immunotherapeutic agent, which is intended as a “functional cure” for patients with chronic hepatitis B virus (HBV) infection. The HEP-PEP trial aims to examine the safety, tolerability, and efficacy of three escalating doses of ISA Pharmaceuticals’ synthetic long peptide immunotherapy vaccine, ISA104, in comparison to a placebo among patients with HBV. Leon Hooftman, MD, expressed his delight at this significant milestone in their mission to develop an effective treatment for chronic hepatitis B virus infection. Study investigators from Erasmus MC University…
This insightful article discusses the limitations and potential of generative artificial intelligence, particularly in the context of science and healthcare. It highlights that generative AI, like ChatGPT, can provide accurate information on non-controversial topics but may exhibit biases and errors when dealing with controversial or evolving subjects. The author emphasizes the need for a paradigm shift from reductionist science to systems science in healthcare, challenging the validity of randomized controlled trials (RCTs). They argue that the transition is essential for building a sustainable healthcare system and advocate for a human-computing symbiosis to generate intelligent solutions. Ultimately, the author calls for…
AI chatbots have the potential to provide accurate information on frequently asked questions related to cancer. However, they might not be as reliable when it comes to offering precise cancer treatment recommendations, according to recent research. The study suggests that while AI chatbots can be beneficial in some areas, there are limitations to their capabilities, especially in more complex and nuanced medical scenarios.
On September 1st, 2023, Gastro Health, a prominent medical group specializing in digestive and liver health, announced the completion of its partnership with Gastroenterology Consultants of Polk County in Davenport, Florida. This marks Gastro Health’s sixth collaboration in the Central Florida region. The Gastroenterology Consultants of Polk County will be joining with one board-certified gastroenterologist, Dr. Devendra S. Kahlon, and an advanced practice provider (APP). Dr. Kahlon and his team are known for treating a variety of gastrointestinal disorders and are committed to providing top-notch, personalized gastrointestinal care to the community. Joseph Garcia, the CEO of Gastro Health, expressed enthusiasm…